[ad_1]
The drug company had “voluntarily suspended” clinical trials after a patient fell ill.
A few days after clinical trials of its corona vaccine were suspended, British-Swedish pharmaceutical company AstraZeneca resumed trials. After safety was confirmed by the competent supervisory authority, human testing of AZD1222 vaccine began again in Britain, the company announced on Saturday.
On Wednesday, AstraZeneca announced that it “voluntarily suspended” clinical trials after a subject became ill. It was not disclosed what the patient became ill with.
Discontinuation of testing is a “routine measure”
Then an independent panel of experts examined the case. Like AstraZeneca, the World Health Organization (WHO) also stated that such interruption in a series of tests is a routine measure. In its statement on Saturday, the pharmaceutical company said it is “committed to the safety of trial participants and the highest standards in clinical trials.”
The AstraZeneca preparation is one of the nine potential vaccines in the world against the new coronavirus that are already in the final phase of testing III. The British-Swedish group developed the product together with the University of Oxford.
In addition to testing in the UK, AstraZeneca has also been investigating the effects of AZD1222 on 30,000 volunteers in a dozen US cities since late August. There are also smaller groups of test subjects in Brazil and other South American countries. The EU, US and other countries have already entered into agreements to supply the vaccine with the pharmaceutical company.
(APA / AFP)
